REUMATOLOGÍA

2011

Artículos

Carrión M, Juarranz Y, Pérez García S, Jimeno R, Pablos JL, Gomariz RP, et al. RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide. Arthritis Rheum. 2011;63(6):1626-36.

Izquierdo E, Cañete JD, Celis R, Del Rey MJ, Usategui A, Marsal S, et al. Synovial fibroblast hyperplasia in rheumatoid arthritis: clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapy. Arthritis Rheum. 2011;63(9):2575-83.

Martín JS. Necrosis cutánea en paciente con arteritis temporal. Reumatol Clin. 2011;7(3):198-9

Reyero F, Ponce G, Rodríguez Jiménez R, Fernández Dapica P, Taboada D, Martín V, et al. High frequency of childhood ADHD history in women with fibromyalgia. Eur Psychiatry. 2011;26(8):482-3.

Santiago B, Calonge E, Del Rey MJ, Gutiérrez Cañas I, Izquierdo E, Usategui A, et al. CXCL12 gene expression is upregulated by hypoxia and growth arrest but not by inflammatory cytokines in rheumatoid synovial fibroblasts. Cytokine. 2011;53(2):184-90.

.

2012

Artículos

Del Rey MJ, Usategui A, Izquierdo E, Cañete JD, Blanco FJ, Criado G, et al. Transcriptome analysis reveals specific changes in osteoarthritis synovial fibroblasts. Ann Rheum Dis. 2012;71(2):275-80.

Gonzalo E, Toldos O, Martínez Vidal MP, Ordóñez MC, Santiago B, Fernández Nebro A, et al. Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis. Arthritis Res Ther. 2012;14(3):R126.

Jaén F, Sanz Gallardo MI, Arrazola MP, García de Codes A, De Juanes A, Resines C, et al. Estudio multicéntrico sobre la incidencia de infección en prótesis de rodilla. Rev Esp Cir Ortop Traumatol. 2012;56(1):38-45.

Santiago B, Izquierdo E, Rueda P, Del Rey MJ, Criado G, Usategui A, et al. CXCL12γ isoform is expressed on endothelial and dendritic cells in rheumatoid arthritis synovium and regulates T cell activation. Arthritis Rheum. 2012;64(2):409-17.

.

2013

Artículos

Bossini Castillo L, Martin JE, Broen J, Simeon CP, Beretta L, Gorlova OY, et al. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis. 2013;72(4):602-7 [PubMed]

Cañete JD, Pablos JL. Biologic therapy in rheumatoid arthritis. Curr Top Med Chem. 2013;13(6):752-9 [PubMed]

Carmona FD, Cénit MC, Díaz Gallo LM, Broen JCA, Simeón CP, Carreira PE, et al. New insight on the Xq28 association with systemic sclerosis. Ann Rheum Dis. 2013;72(12):2032-8 [PubMed]

Carmona FD, Martin JE, Beretta L, Simeón CP, Carreira PE, Callejas JL, et al. The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis. PLoS One. 2013;8(1):e54419 [PubMed]

Carrión M, Juarranz Y, Martínez C, González Álvaro I, Pablos JL, Gutiérrez Cañas I, et al. IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts. Rheumatology (Oxford). 2013;52(12):2177-86 [PubMed]

Carrión M, Pérez-García S, Jimeno R, Juarranz Y, González-Álvaro I, Pablos JL et al. Inflammatory mediators alter interleukin-17 receptor, interleukin-12 and -23 expression in human osteoarthritic and rheumatoid arthritis synovial fibroblasts: immunomodulation by vasoactive intestinal Peptide. Neuroimmunomodulation. 2013;20(5):274-84 [PubMed]

Castellanos González M, Sánchez Barrueco A, Esther Joven B. Bilateral ulcers on the face as a manifestation of granulomatosis with polyangiitis (Wegener’s). Arthritis Rheum. 2013;65(9):2367 [PubMed]

De Inocencio Arocena J, Tejada Palacios P, Barcelo Mendiguchia A, Enríquez Merayo E. Clarifications on the article “Sarcoidosis simulating a non-Langerhans cell histiocytosis, treated with tumour necrosis factor antagonists”. An Pediatr. 2013;78(4):281-281 [PubMed]

Díaz Gallo LM, Simeón CP, Broen JC, Ortego Centeno N, Beretta L, Vonk MC, et al. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility. Ann Rheum Dis. 2013;72(7):1233-8 [PubMed]

Domínguez-Pinilla N, Del Fresno-Valencia MR, de Inocencio Arocena J, Enríquez
Merayo E. [Sinus bradycardia secondary to the use of pulse corticosteroids]. An
Pediatr (Barc). 2014 May;80(5):331-2. [PubMed]

García Bermúdez M, López Mejías R, Genre F, Castañeda S, González Juanatey C, Llorca J, et al. Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. Tissue Antigens. 2013;82(6):405-9

Gonzalo Gil E, Criado G, Santiago B, Dotor J, Pablos JL, Galindo M. Transforming growth factor (TGF)-β signalling is increased in rheumatoid synovium but TGF-β blockade does not modify experimental arthritis. Clin Exp Immunol. 2013;174(2):245-55 [PubMed]

Heijnen IAFM, Foocharoen C, Bannert B, Carreira PE, Caporali R, Smith V, et al. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study. Clin Exp Rheumatol. 2013;31(2 Suppl 76):96-102 [PubMed]

Ingegnoli F, Ardoino I, Boracchi P, Cutolo M, EUSTAR co-authors. Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database. Microvasc Res. 2013;89:122-8 [PubMed]

López Mejías R, Genre F, García Bermúdez M, Castañeda S, González Juanatey C, Llorca J, et al. The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis. Tissue Antigens. 2013;82(5):344-7 [PubMed]

Martin JE, Assassi S, Díaz Gallo LM, Broen JC, Simeón CP, Castellvi I, et al. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet. 2013;22(19):4021-9 [PubMed]

Pablos JL, Cañete JD. Immunopathology of rheumatoid arthritis. Curr Top Med Chem. 2013;13(6):705-11 [PubMed]

Schneeberger D, Tyndall A, Kay J, Sondergaard KH, Carreira PE, Morgiel E, et al. Systemic sclerosis without antinuclear antibodies or Raynaud’s phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database. Rheumatology. 2013;52(3):560-7 [PubMed]

Serrano A, David Carmona F, Castañeda S, Solans R, Hernández Rodríguez J, Cid MC, et al. Evidence of association of the NLRP1 gene with giant cell arteritis. Ann Rheum Dis. 2013;72(4):628-30 [PubMed]

Serrano A, Márquez A, Mackie SL, Carmona FD, Solans R, Miranda-Filloy JA, et al. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis. Ann Rheum Dis. 2013;72(11):1882-6 [PubMed]

Teruel M, Simeon CP, Broen J, Carreira P, García de la Peña P, Aguirre MÁ, et al. The role of the NLRP1 gene in systemic sclerosis: a replication study. Clin Exp Rheumatol. 2013;31(2 Suppl 76):187-8 [PubMed]

Usategui A, Criado G, Izquierdo E, Del Rey MJ, Carreira PE, Ortiz P, et al. A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis. Ann Rheum Dis.  2013;72(12):2018-23 [PubMed]

Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747-55 [PubMed]

Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an american college of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737-47 [PubMed]

Congresos

Armas González E, Díaz Martín A, Domínguez Luis MJ, Arce Franco MT, Herrera García A, Hernández V, et al. Role of CD20+B cells as antigen-presenting cells in arthritis. Arthritis Rheum. 2013;65:S393 [Annual Meeting of the American College of Rheumatology (77. 2013. San Diego, CA.) y Annual Meeting of the Association of Rheumatology Health Professionals (48. San Diego, CA. 2013)]

Carmona FD, Mackie SL, Serrano A, Márquez A, Solans R, Miranda Filloy JA, et al. The functional PTPN22 variant R620W is strongly associated with giant cell artetitis predisposition. Arthritis Rheum. 2013;65:S383 [Annual Meeting of the American College of Rheumatology (77. 2013. San Diego, CA.) y Annual Meeting of the Association of Rheumatology Health Professionals (48. San Diego, CA. 2013)]

Lajas C, Andreu JL, Balsa A, Crespo M, González CM, Illera O, et al. Consensus statement on the diagnosis and management of comorbidity in rheumatoid arthritis. Arthritis Rheum. 2013;65:S179-180 [Annual Meeting of the American College of Rheumatology (77. 2013. San Diego, CA.) y Annual Meeting of the Association of Rheumatology Health Professionals (48. San Diego, CA. 2013)]

López Mejías R, Genre F, García Bermúdez M, Castañeda S, González Juanatey C, Llorca J, et al. The 11q23.3 genomic region-rs964184- is associated with cardiovascular disease in patients with rheumatoid arthritis. Arthritis Rheum. 2013;65:S584 [Annual Meeting of the American College of Rheumatology (77. San Diego, CA. 2013) y Annual Meeting of the Association of Rheumatology Health Professionals (48. San Diego, CA. 2013)]

Loricera J, Blanco R, Castañeda S, Humbría A, Melchor S, Calvo Alén J, et al. Tocilizumab in refractory aortitis: A multicenter study of 13 patients. Arthritis Rheum. 2013;65:S714-5 [Annual Meeting of the American College of Rheumatology (77. 2013. San Diego, CA.) y Annual Meeting of the Association of Rheumatology Health Professionals (48. San Diego, CA. 2013)]

Ezequiel Martín J, Simeón CP, Ortego Centeno N, Carreira P, González Gay MA, Hunzelmann N, et al. Identification of major histocompatibility complex class II alleles associated with systemic sclerosis through imputation strategy. Arthritis Rheum. 2013;65:S70 [Annual Meeting of the American College of Rheumatology (77. San Diego, CA. 2013) y Annual Meeting of the Association of Rheumatology Health Professionals (48. San Diego, CA. 2013)]

Ortiz Sanjuan F, Calvo Río V, Blanco R, Beltrán E, Sánchez Burson J, Mesquida M, et al. Biologic therapy in refractory uveitis of Behcet’s Syndrome: Switching and dose modification. Multicenter study of 124 patients. Arthritis Rheum. 2013;65:S1118-9 [Annual Meeting of the American College of Rheumatology (77. San Diego, CA. 2013) y Annual Meeting of the Association of Rheumatology Health Professionals (48. San Diego, CA. 2013)]

Ortiz Sanjuan F, Calvo Río V, Blanco R, Beltrán E, Sánchez Burson J, Mesquida M, et al. Short and long-term biological therapy in refractory uveitis of Behcet’s Syndrome. Multicenter study of 124 patients. Arthritis Rheum. 2013;65:S743-4 [Annual Meeting of the American College of Rheumatology (77. San Diego, CA. 2013) y Annual Meeting of the Association of Rheumatology Health Professionals (48. San Diego, CA. 2013)]

Rodríguez Almaraz E, Gonzalo Gil E, Herráiz I, Gómez Arriaga PI, Vallejo P, López Jiménez EA, et al. Predictive markers of preeclampsia during pregnancy in patients with systemic erithematosus lupus and / or antiphospholipid syndrome. Arthritis Rheum. 2013;65:S1088-9 [Annual Meeting of the American College of Rheumatology (77. San Diego, CA. 2013) y Annual Meeting of the Association of Rheumatology Health Professionals (48. San Diego, CA. 2013)]

.

2014

Artículos

Baxter AE, Russell RA, Duncan CJA, Moore MD, Willberg CB, Pablos JL, et al. Macrophage infection via selective capture of HIV-1-infected CD4+ T cells. Cell Host Microbe. 2014;16(6):711-21 [PubMed]
JCR Factor de Impacto: 12,328
JCR Cuartil: Q1
JCR Decil: D1
JCR Posición: 5/119
JCR Categoría: MICROBIOLOGY

Calvo Río V, Blanco R, Beltrán E, Sánchez Bursón J, Mesquida M, Adán A, et al. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet’s disease: a 1-year follow-up study of 124 patients. Rheumatology (Oxford). 2014;53(12):2223-31 [PubMed]
JCR Factor de Impacto: 4,475
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 6/32
JCR Categoría: RHEUMATOLOGY

Carrión M, Juarranz Y, Seoane IV, Martínez C, González Ávaro I, Pablos JL, et al. VIP modulates IL-22R1 expression and prevents the contribution of rheumatoid synovial fibroblasts to IL-22-mediated joint destruction. J Mol Neurosci. 2014;52(1):10-7 [PubMed]
JCR Factor de Impacto: 2,343
JCR Cuartil: Q3
JCR Decil: D6
JCR Posición: 174/290
JCR Categoría: BIOCHEMISTRY & MOLECULAR BILOGY

Cuadrado MJ, Bertolaccini ML, Seed PT, Tektonidou MG, Aguirre A, Mico L, et al. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). Rheumatology. 2014;53(2):275-84 [PubMed]
JCR Factor de Impacto: 4,475
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 6/32
JCR Categoría: RHEUMATOLOGY

Del Fresno MR, Peralta JE, Granados MÁ, Enríquez E, Domínguez Pinilla N, de Inocencio J. Intravenous immunoglobulin therapy for refractory recurrent pericarditis. Pediatrics. 2014;134(5):e1441-6 [PubMed]
JCR Factor de Impacto: 5,473
JCR Cuartil: Q1
JCR Decil: D1
JCR Posición: 4/120
JCR Categoría: PEDIATRICS

Del Rey MJ, Fare R, Izquierdo E, Usategui A, Rodríguez Fernández JL, Suárez-Fueyo A, et al. Clinicopathological correlations of podoplanin (gp38) expression in rheumatoid synovium and its potential contribution to fibroblast platelet crosstalk. PLoS One. 2014;9(6):e99607-e99607 [PubMed]
JCR Factor de Impacto: 3,234
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 9/57
JCR Categoría: MULTIDISCIPLINARY SCIENCES

Domínguez-Pinilla N, Del Fresno-Valencia MR, de Inocencio Arocena J, Enríquez
Merayo E. [Sinus bradycardia secondary to the use of pulse corticosteroids]. An
Pediatr (Barc). 2014;80(5):331-2. [PubMed] JCR Factor de Impacto: 0,833
JCR Cuartil: Q4
JCR Decil: D9
JCR Posición: 104/120
JCR Categoría: PEDIATRICS

Genre F, López Mejías R, García Bermúdez M, Castañeda S, González Juanatey C, Llorca J, et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. PLoS One. 2014;9(9):e106823 [PubMed]
JCR Factor de Impacto: 3,234
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 9/57
JCR Categoría:MULTIDISCIPLINARY SCIENCES

Ghrénassia E, Avouac J, Khanna D, Derk CT, Distler O, Suliman YA, et al. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR Case-control Study. J Rheumatol. 2014;41(1):99-105 [PubMed]
JCR Factor de Impacto: 3,187
JCR Cuartil: Q2
JCR Decil: D4
JCR Posición: 11/32
JCR Categoría: RHEUMATOLOGY

López Mejías R, Genre F, García Bermúdez M, Ubilla B, Castañeda S, Llorca J, et al. Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. Mediators Inflamm. 2014;756279 [PubMed]
JCR Factor de Impacto: 3,236
JCR Cuartil: Q2
JCR Decil: D4
JCR Posición: 58/148
JCR Categoría: IMMUNOLOGY

Mayes MD, Bossini-Castillo L, Gorlova O, Martin JE, Zhou X, Chen WV, et al. Immunochip analysis identifies multiple susceptibility Loci for systemic sclerosis. Am J Hum Genet. 2014;94(1):47-61 [PubMed]
JCR Factor de Impacto: 10,931
JCR Cuartil: Q1
JCR Decil: D1
JCR Posición: 6/167
JCR Categoría: GENETICS & HEREDITY

Ramírez J, Ruiz Esquide V, Pomes I, Celis R, Cuervo A, Hernández MV, et al. Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers. Arthritis Res Ther. 2014;16(1):R5 [PubMed]
JCR Factor de Impacto: 3,753
JCR Cuartil: Q2
JCR Decil: D3
JCR Posición: 9/32
JCR Categoría: RHEUMATOLOGY

Rúa Figueroa I, López Longo FJ, Calvo Alén J, Galindo Izquierdo M, Loza E, García de Yébenes MJ, et al. National registry of patients with systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and methodology. Reumatol Clin. 2014;10(1):17-24 [PubMed]
JCR Factor de Impacto: – –
JCR Cuartil: – –
JCR Decil: – –
JCR Posición: – –
JCR Categoría: – –

Ruiz García R, Serrano M, Martínez Flores JA, Mora S, Morillas L, Martín Mola MA, et al. Isolated IgA anti- beta2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome. J Immunol Res. 2014;2014:704395-704395 [PubMed]
JCR Factor de Impacto: – –
JCR Cuartil: Q4
JCR Decil: D10
JCR Posición: 148/148
JCR Categoría: IMMUNOLOGY

Usategui A, Criado G, Del Rey MJ, Faré R, Pablos JL. Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma. Arch Dermatol Res. 2014;306(8):757-61 [PubMed]
JCR Factor de Impacto: 1,902
JCR Cuartil: Q2
JCR Decil: D4
JCR Posición: 23/63
JCR Categoría: DERMATOLOGY

Congresos

Bossini Castillo L, Gorlova O, Assassi S, Reveille JD, Carreira P, Simeón CP, et al. Genetic markers of susceptibility and interstitial lung disease in systemic sclerosis patients: an immunochip study. Clin Exp Rheumatol. 2014;32(2):S18-9 [Systemic Sclerosis Wolrd Congress (3. Roma, Italia. 2014)]

Carreira P, Carmona L, Joven B. Performance of the old 1980 ACR and the new ACR-EULAR Systemic Sclerosis (SSC) classification criteria in patients with limited cutaneous SSC. Clin Exp Rheumatol. 2014;32(2):S6 [Systemic Sclerosis Wolrd Congress (3. Roma, Italia. 2014)]

Carreira P, Carmona L, Joven B, Ruiz Cano MJ, Escribano P, Gómez Sánchez MA. Pulmonary arterial hypertension, classification criteria. Clin Exp Rheumatol. 2014;32(2):S86 [Systemic Sclerosis Wolrd Congress (3. Roma, Italia. 2014)]

Ghrénassia E, Avouac J, Khanna D, Derk CT, Distler O, Airo P, et al. Prevalence, correlates and outcomes of gastric antral vascular ectasia. Clin Exp Rheumatol. 2014;32(2):S10-1 [Systemic Sclerosis Wolrd Congress (3. Roma, Italia. 2014)]

Hachulla E, Clerson P, Airo P, Cuomo G, Allanore Y, Caramaschi P, et al. Value of systolic pulmonary arterial pressure as a prognostic factor of death in systemic sclerosis eustar population. Clin Exp Rheumatol. 2014;32(2):S32 [Systemic Sclerosis Wolrd Congress (3. Roma, Italia. 2014)]

.

2015

Artículos

Armas González E, Díaz Martín A, Domínguez Luis MJ, Arce Franco MT, Herrera García A, Hernández Hernández MV, et al. Differential antigen-presenting B cell phenotypes from synovial microenvironment of patients with rheumatoid and psoriatic arthritis. J Rheumatol. 2015;42(10):1825-34 [PubMed]

Brand M, Hollaender R, Rosenberg D, Scott M, Hunsche E, Tyndall A, et al. An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database. Clin Exp Rheumatol. 33(4 Suppl 91):S47-54 [PubMed]

Calvo I, Antón J, Bustabad S, Camacho M, De Inocencio J, Gamir ML, et al. Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset. Rheumatol Int. 2015;35(10):1615-24 [PubMed]

Cañete JD, Celis R, Yeremenko N, Sanmartí R, van Duivenvoorde L, Ramírez J, et al. Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis. Arthritis Res Ther. 2015;17:173 [PubMed]

Fernández Nebro A, Rúa Figueroa Í, López Longo FJ, Galindo Izquierdo M, Calvo Alén J, Olivé Marqués A, et al. Cardiovascular events in systemic lupus erythematosus: a nationwide study in Spain from the RELESSER Registry. Medicine (Baltimore). 2015;94(29):e1183 [PubMed]

García Bermúdez M, López Mejías R, Genre F, Castañeda S, Corrales A, Llorca J, et al. Lack of association between JAK3 gene polymorphisms and cardiovascular disease in spanish patients with rheumatoid arthritis. Biomed Res Int. 2015;2015:318364 [PubMed]

García Martos Á, García González JA, Mateo I. Good response to surgical treatment and mycophenolate in woman with inflammatory pseudotunor secondary to ANCA positive vasculitis. Reumatol Clin. 2015;11(1):45-7 [PubMed]

Hachulla E, Clerson P, Airò P, Cuomo G, Allanore Y, Caramaschi P, et al. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population. Rheumatology (Oxford). 2015;54(7):1262-9 [PubMed]

Ingegnoli F, Boracchi P, Gualtierotti R, Smith V, Cutolo M, Foeldvari I, et al. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study. Microvasc Res. 2015;102:19-24.

Minoia F, Davì S, Horne A, Bovis F, Demirkaya E, Akikusa J, et al. Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Rheumatol. 2015;42(6):994-1001 [PubMed]

Montes A, Pérez Pampín E, Navarro Sarabia F, Moreira V, De la Serna AR, Magallares B, et al. Rheumatoid arthritis response to treatment across IgG1 allotype – anti-TNF incompatibility: a case-only study. Arthritis Res Ther. 2015;17(1):63 [PubMed]

Ochoa E, Martín JE, Assasi S, Beretta L, Carreira P, Guillén A, et al. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis. Clin Exp Rheumatol. 2015;33(4 Suppl 91):S31-5 [PubMed]

Ortiz Sanjuán F, Blanco R, Riancho Zarrabeitia L, Castañeda S, Olivé A, Riveros A, et al. Efficacy of anakinra in refractory adult-onset Still’s disease: multicenter study of 41 patients and literature review. Medicine (Baltimore). 2015;94(39):e1554 [PubMed]

Palacios BS, Estrada Capetillo L, Izquierdo E, Criado G, Nieto C, Municio C, et al. Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile. J Pathol. 2015;235(3):515-26 [PubMed]

Pego Reigosa JM, Rúa Figueroa Í, López Longo FJ, Galindo Izquierdo M, Calvo Alén J, Olivé Marqués A, et al. Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus. Lupus. 2015;24(7):720-9 [PubMed]

Rúa Figueroa Í, Richi P, López Longo FJ, Galindo M, Calvo Alén J, Olivé Marqués A, et al. Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences. Medicine (Baltimore). 2015;94(1):e267 [PubMed]

Sandmeier B, Jäger VK, Nagy G, Carreira PE, Tzankov A, Widuchowska M, et al. Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database. Clin Exp Rheumatol. 2015;33(4 Suppl 91):S75-9 [PubMed]

Valin A, Pablos JL. The role of the transcriptional regulation of stromal cells in chronic inflammation. Biomolecules. 2015;5(4):2723-57 [PubMed]

Zarco P, González CM, Rodríguez de la Serna A, Peiró E, Mateo I, Linares L, et al. Manifestaciones extraarticulares en pacientes con espondiloartritis. Características basales de la cohorte de pacientes con espondiloartritis del  estudio AQUILES. Reumatol Clin. 2015;11(2):83-9 [PubMed]

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión /  Cambiar )

Google photo

Estás comentando usando tu cuenta de Google. Cerrar sesión /  Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión /  Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión /  Cambiar )

Conectando a %s